Chronic Liver Disease clinical trials

Explore recruiting chronic liver disease clinical trials.

Recruiting chronic liver disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Liver Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Austria, Italy, Czechia, Romania, Sweden, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pharmacokinetics, pharmacodynamics, safety, and tolerability of an acetonic milk thistle extract, standardized to silymarin, in subjects with MASLD

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Multicenter, randomized, double-blind, comparative clinical trial to assess the efficacy of Zinc Acexamate versus a placebo in improving the prognosis of patients with advanced chronic liver disease (cACLD).

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Compensated Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Spain, Hungary, Netherlands, Belgium, Bulgaria, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Telmisartan for portal hypertension in patients with compensated advanced chronic liver disease: A randomized placebo-controlled, double-blind trial

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy of simvastatin reducing liver fibrosis in patients with advanced fibrosis due to alcohol: a randomized, double-blind, placebo-controlled clinical trial.

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Chronic Liver Disease trials by city

Chronic Liver Disease in Toronto Chronic Liver Disease in Vancouver Chronic Liver Disease in Montreal Chronic Liver Disease in Calgary Chronic Liver Disease in Edmonton Chronic Liver Disease in Ottawa Chronic Liver Disease in Winnipeg Chronic Liver Disease in Quebec City Chronic Liver Disease in Hamilton Chronic Liver Disease in Kitchener Chronic Liver Disease in London Chronic Liver Disease in Halifax Chronic Liver Disease in New York Chronic Liver Disease in Los Angeles Chronic Liver Disease in Chicago Chronic Liver Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease